Disrupting Obesity Treatment with Precision GIP Antagonism for More Tolerable, Durable Weight Management
10:00 am - Thursday 10th December 2026
- Exploring the biology of GIP to uncover a differentiated pathway to durable weight loss and long-term cardiometabolic benefit
- Addressing the tolerability and adherence challenges of current obesity therapies through highly specific GIP antagonism
- Shifting the focus from short-term weight loss to sustained disease management with lasting clinical impact
